CoChat

Losartan, an angiotensin II (AT1) receptor antagonist, preserves cerebral blood flow in hypertensive patients with a history of stroke

Moriwaki, H, Uno, H, Nagakane, Y, Hayashida, K, Miyashita, K, Naritomi, H · 2004 · Journal of Human Hypertension

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Abstract

In patients with severe hypertension, chronic heart failure or a history of stroke, the lower limit of autoregulation of cerebral blood flow (CBF) is shifted to higher levels of blood pressure (BP) than those observed in healthy subjects. The aim of pharmacotherapy for hypertensive patients with an impaired autoregulation of CBF should be to reduce BP while preserving an appropriate CBF. In the present study, 16 hypertensive patients who had had an episode of stroke more than 4 weeks previously were administered the angiotensin II (AT1) receptor antagonist losartan at daily doses of 25-100 mg for 4 weeks. Systolic and diastolic blood pressures were recorded for 24 h using an ambulatory BP monitoring system. CBF in both hemispheres of the cerebrum and cerebellum was quantified using single photon emission tomography with N-isopropyl-p-[123I]iodoamphetamine. At baseline, CBF was 29.7 +/- 6.7 ml/min/100 g in the cerebrum and 31.5 +/- 7.5 ml/min/100 g in the cerebellum. At the end of treatment, BP was lower, while CBF increased by 7.7% in the cerebrum, and remained at the baseline level in the cerebellum. Thus, CBF was preserved despite the reduction in BP. We consider the use of losartan is advantageous for hypertensive patients with a history of stroke in whom autoregulation of CBF is potentially impaired.

Overview

Integrity signals

Registry

Crossref · 10.1038/sj.jhh.1001735

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 19 references

Research works printed but not linked: 1

  1. Kuriyama Y, Nakamura M, Sawada T, Omae T . Normalization of cerebral blood flow autoregulation after administration of a converting enzyme inhibitor (enalapril) in old stroke patients with hypertension. High Blood Pressure 1992; 1: 239–244.

Cited by

See all 36

Metadata

Authors
Moriwaki, H., Uno, H., Nagakane, Y., Hayashida, K., Miyashita, K., & Naritomi, H.
Affiliations
National Cerebral and Cardiovascular Center (JP)
Corresponding author
Moriwaki, H
Venue
Journal of Human Hypertension
Published
2004-05-06
Volume
18
Issue
10
Pages
693-699
ISSN
  • 0950-9240 (ISSN-L)
  • 1476-5527
OpenAlex
W2036695904
Cited by
36
References
19
Citations by year
2023: 1 · 2021: 3 · 2020: 1 · 2019: 1 · 2018: 4 · 2017: 2 · 2015: 1 · 2014: 1 · 2013: 1 · 2012: 2
FWCI
1.76
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Journal of Human Hypertension (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
  • Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury and Neurovascular Disturbances
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
Keywords
losartan, angiotensin II AT1 receptor antagonists, cerebral blood flow, cerebral autoregulation, hypertension, stroke, blood pressure reduction, cerebellar blood flow, ambulatory blood pressure monitoring
MeSH terms
Aged, Blood Pressure, Brain, Cerebrovascular Circulation, Female, Humans, Hypertension, Male, Middle Aged, Tomography, Emission-Computed, Single-Photon, Treatment Outcome, Blood Pressure Monitoring, Ambulatory, Radiopharmaceuticals, Losartan, Iofetamine, Stroke, Angiotensin II Type 1 Receptor Blockers

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Losartan, an angiotensin II (AT1) receptor antagonist, preserves cerebral blood flow in hypertensive patients with a history of stroke. https://app.cochat.ai/papers/10.1038/sj.jhh.1001735
The paper
Moriwaki, H., Uno, H., Nagakane, Y., Hayashida, K., Miyashita, K., & Naritomi, H. (2004). Losartan, an angiotensin II (AT1) receptor antagonist, preserves cerebral blood flow in hypertensive patients with a history of stroke. Journal of Human Hypertension. https://doi.org/10.1038/sj.jhh.1001735

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.